EP4039814 - METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCE, RECOMBINANT CELLS AND METHOD FOR PRODUCING SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.07.2022 Database last updated on 15.07.2024 | |
Former | The international publication has been made Status updated on 10.04.2021 | Most recent event Tooltip | 03.05.2024 | New entry: Application deemed to be withdrawn: despatch of communication + time limit | Applicant(s) | For all designated states Kyushu University, National University Corporation 744, Motooka Nishi-ku Fukuoka-shi Fukuoka 819-0395 / JP | For all designated states National University Corporation Chiba University 1-33, Yayoi-cho Inage-ku Chiba-shi, Chiba 263-8522 / JP | For all designated states Kyowa Hakko Bio Co., Ltd. 1-6-1 Otemachi Chiyoda-ku Tokyo 100-8185 / JP | [2022/32] | Inventor(s) | 01 /
KAMIHIRA Masamichi c/o KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, 744, Motooka, Nishi-ku Fukuoka-shi, Fukuoka 819-0395 / JP | 02 /
KAWABE Yoshinori c/o KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, 744, Motooka, Nishi-ku Fukuoka-shi, Fukuoka 819-0395 / JP | 03 /
SAGAWA Kosuke c/o KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION, 744, Motooka, Nishi-ku Fukuoka-shi, Fukuoka 819-0395 / JP | 04 /
TOIDA Toshihiko c/o Graduate School of Pharmaceutical Sciences, NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY 1-8-1, Inohana, Chuo-ku Chiba-shi, Chiba 260-8675 / JP | 05 /
KOIZUMI Satoshi c/o KYOWA HAKKO BIO CO., LTD., 1-6-1, Otemachi, Chiyoda-ku Tokyo 100-8185 / JP | [2022/32] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE | [2022/32] | Application number, filing date | 20872500.2 | 02.10.2020 | [2022/32] | WO2020JP37626 | Priority number, date | JP20190182467 | 02.10.2019 Original published format: JP 2019182467 | [2022/32] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021066167 | Date: | 08.04.2021 | Language: | JA | [2021/14] | Type: | A1 Application with search report | No.: | EP4039814 | Date: | 10.08.2022 | Language: | EN | [2022/32] | Search report(s) | International search report - published on: | JP | 08.04.2021 | (Supplementary) European search report - dispatched on: | EP | 12.09.2023 | Classification | IPC: | C12P19/26, C12P19/04, C12N5/10, C07K14/705, C12N15/85 | [2023/41] | CPC: |
C07K14/705 (EP);
C12P19/26 (EP,CN);
C08B37/0075 (EP,US);
C07K14/4725 (CN);
C08L5/10 (EP);
C12N15/63 (US);
C12N15/85 (EP,CN);
C12N5/0682 (CN,US);
C12N5/10 (US);
C12N9/13 (EP,CN);
C12Y208/02008 (EP,CN);
C12Y208/02023 (EP,CN);
C12N2510/02 (CN);
C12N2800/107 (CN);
C12N2800/90 (EP);
C12N2840/203 (EP)
(-)
|
Former IPC [2022/32] | C12P19/04, C12N5/10, C12N15/12, C12N15/54, C12N15/63 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/32] | Title | German: | VERFAHREN ZUR HERSTELLUNG VON HEPARINÄHNLICHEN SUBSTANZEN, REKOMBINANTE ZELLEN UND VERFAHREN ZU DEREN HERSTELLUNG | [2022/32] | English: | METHOD FOR PRODUCING HEPARIN-LIKE SUBSTANCE, RECOMBINANT CELLS AND METHOD FOR PRODUCING SAME | [2022/32] | French: | PROCÉDÉ DE PRODUCTION D'UNE SUBSTANCE DU TYPE HÉPARINE, CELLULES RECOMBINANTES ET LEUR PROCÉDÉ DE PRODUCTION | [2022/32] | Entry into regional phase | 30.03.2022 | Translation filed | 30.03.2022 | National basic fee paid | 30.03.2022 | Search fee paid | 30.03.2022 | Designation fee(s) paid | 30.03.2022 | Examination fee paid | Examination procedure | 30.03.2022 | Examination requested [2022/32] | 26.10.2022 | Amendment by applicant (claims and/or description) | 02.05.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | Fees paid | Renewal fee | 24.10.2022 | Renewal fee patent year 03 | 23.10.2023 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XA]US5486599 (SAUNDERS SCOTT [US], et al) [X] 11,13 * page 2, column 3, line 9 - line 24; examples 6, 9 * [A] 1,6,10,14; | [A]WO2018112434 (TEGA THERAPEUTICS INC [US]) [A] 1,11,14* the whole document *; | [A]US10385143 (WHITELOCK JOHN M [AU], et al) [A] 1,11,14 * the whole document * | International search | [XA]WO0140267 (YEDA RES & DEV [IL], et al) [X] 11,13-14 * 13 31-13 3, 2 * [A] 1-10, 12; | [A]US2004043447 (SARIBAS SAMI [US], et al) [A] 1-12 * [0006] - [0 00 7] *; | [A]JP2008515417 [A] 1-12; | [A] - BAIK, J. Y. et al., "Metabolic engineering of Chinese hamster ovary cells: Towards a bioengineered heparin", Metabolic Engineering, (20120000), vol. 14, doi:10.1016/j.ymben.2012.01.008, ISSN 1096-7176, pages 81 - 90, XP028466088 [A] 1-12 * 8 1 8 3 2,2. 8 5 -8 6 3.2 . -3.3.,8 6 2 * DOI: http://dx.doi.org/10.1016/j.ymben.2012.01.008 | [A] - JALKANEN, Markku, Elenius Klaus, Rapraeger Alan, "Syndecan: Regulator of cell morphology and growth factor action at the cell-matrix interface", Trends in Glycoscience and Glycotechnology, (19930000), vol. 5, no. 22, doi:10.4052/tigg.5.107, ISSN 0915-7352, pages 107 - 120, XP055811043 [A] 1-12 * 1 0 7 * DOI: http://dx.doi.org/10.4052/tigg.5.107 | [A] - YANG, Yang, Yaccoby Shmuel, Liu Wei, Langford J. Kevin, Pumphrey Carla Y., Theus Allison, Epstein Joshua, Sanderson Ralph D., "Soluble syndecan-1 promotes growth of myeloma tumors in vivo", Blood, (20020000), vol. 100, no. 2, doi:10.1182/blood.V100.2.610, ISSN 0006-4971, pages 610 - 617, XP055811048 [A] 1-12 * 610, 611 3 * DOI: http://dx.doi.org/10.1182/blood.V100.2.610 | by applicant | JPS63299 | JPH02227075 | JPH0322979 | WO9710354 | US6001358 | WO2010143698 | JP2019182467 | - GUERRINI et al., Nat. Biotechnol., (20080000), vol. 26, pages 669 - 675 | - Trends in Glycoscience and Glycotechnology, (19930000), vol. 5, no. 22, pages 107 - 120 | - Journal of Experimental Medicine, (19580000), vol. 108, page 945 | - Proc. Natl. Acad. Sci. USA, (19680000), vol. 60, page 1275 | - Genetics, (19680000), vol. 55, page 513 | - Chromosoma, (19730000), vol. 41, page 129 | - Methods in Cell Science, (19960000), vol. 18, page 115 | - Radiation Research, (19970000), vol. 148, page 260 | - Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216 | - Proc. Natl. Acad. Sci., (19680000), vol. 60, page 1275 | - Cell, (19750000), vol. 6, page 121 | - Molecular Cell Genetics, pages 883 - 900 | - BAIL JY et al., Metab Eng, (20120000), vol. 14, pages 81 - 90 | - "NCBI", Database accession no. NM _001006946.1 | - Nature, (19870000), vol. 329, page 840 | - Nucleic Acids Research, (19820000), vol. 10, page 6487 | - Proc. Natl. Acad. Sci. USA, (19820000), vol. 79, page 6409 | - Gene, (19850000), vol. 34, page 315 | - Nucleic Acids Research, (19850000), vol. 13, page 4431 | - Proc. Natl. Acad. Sci. USA, (19850000), vol. 82, page 488 | - J. Mol. Biol., (19900000), vol. 215, page 403 | - Nucleic Acids Res., (19970000), vol. 25, page 3389 | - Genome Res., vol. 7, (19970000), page 649, URL: https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2seq&LINK_LOC=align2seq | - Cytotechnology, (19900000), vol. 3, page 133 | - J. Biochemistry, (19870000), vol. 101, page 1307 | - WIGLER et al., Cell, (19770000), vol. 11, page 223 | - Proc. Natl. Acad. Sci. USA, (19870000), vol. 84, page 7413 | - Cell Biology (Third Edition) A Laboratory Handbook, Elsevier Inc., (20060000), vol. 1 | - BAIL JY et al., Metab Engl, (20120000), vol. 4, pages 81 - 90 |